Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
From epidemiology to precision prevention: Why the latest breast cancer roadmap deserves your attention — Ralf Weiskirchen (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
From epidemiology to precision prevention: Why the latest breast cancer roadmap deserves your attention
RW
Shared by
Ralf Weiskirchen
From epidemiology to precision prevention: Why the latest breast cancer roadmap deserves your attention
Editorial Material
2025
en
Authors
RW
Ralf Weiskirchen
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2015
Cancer prevention as part of precision medicine: ‘plenty to be done’
Bernard W. Stewart
,
Freddie Ian Bray
,
David Forman
,
Hiroko Ohgaki
,
Kurt Straif
,
Andreas Ullrich
,
Christopher P. Wild
Article
2020
Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer
Αngeliki Andrikopoulou
,
Eleni Zografos
,
Michalis Liontos
,
Konstantinos Koutsoukos
,
Meletios A Dimopoulos
,
Flora Zagouri
Article
2022
The epidemiology of breast cancer, a summary overview
Carlo La Vecchia
,
Greta Carioli
Article
2021
Abstract PD11-01: Adherence to the new WCRF cancer prevention recommendations associates with a decreased breast cancer risk
Mélanie Deschasaux
,
Laurent Bourhis
,
Laurent Zelek
,
Eloi Chazelas
,
Charlotte Debras
,
Serge Hercberg
,
Paule Latino‐Martel
,
Chantal Julia
,
Emmanuelle Kesse‐Guyot
,
Bernard Srour
,
Mathilde Touvier
Article
2010
Breast Cancer Epigenetics: From DNA Methylation to microRNAs
Jürgen Veeck
,
Manel Esteller
Discussion(0)
No comments yet. Be the first to comment.